Bone metastasis from epithelial ovarian carcinoma

Russell David Petty; Fiona Gilbert; Andrew W Hutcheon; Tarun K Sarkar; Orla McNally; David Parkin

doi:10.1016/S1470-2045(02)00821-5

Bone metastasis from epithelial ovarian carcinoma

Russell David Petty, Fiona Gilbert, Andrew W Hutcheon, Tarun K Sarkar, Orla McNally, David Parkin

Applied Medicine

Research output: Contribution to journal › Article › peer-review

6 Citations (Scopus)

Original language	English
Pages (from-to)	513
Journal	The Lancet Oncology
Volume	3
Issue number	8
DOIs	https://doi.org/10.1016/S1470-2045(02)00821-5
Publication status	Published - Aug 2002

Keywords

Bone Neoplasms
Carcinoma
Combined Modality Therapy
Disease Progression
Female
Follow-Up Studies
Humans
Middle Aged
Ovarian Neoplasms
Palliative Care
Tomography, X-Ray Computed

Access to Document

10.1016/S1470-2045(02)00821-5

Cite this

@article{ce1151b803c246908e32b57153f34080,

title = "Bone metastasis from epithelial ovarian carcinoma",

keywords = "Bone Neoplasms, Carcinoma, Combined Modality Therapy, Disease Progression, Female, Follow-Up Studies, Humans, Middle Aged, Ovarian Neoplasms, Palliative Care, Tomography, X-Ray Computed",

author = "Petty, {Russell David} and Fiona Gilbert and Hutcheon, {Andrew W} and Sarkar, {Tarun K} and Orla McNally and David Parkin",

year = "2002",

month = aug,

doi = "10.1016/S1470-2045(02)00821-5",

language = "English",

volume = "3",

pages = "513",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Lancet Publishing Group",

number = "8",

}

TY - JOUR

T1 - Bone metastasis from epithelial ovarian carcinoma

AU - Petty, Russell David

AU - Gilbert, Fiona

AU - Hutcheon, Andrew W

AU - Sarkar, Tarun K

AU - McNally, Orla

AU - Parkin, David

PY - 2002/8

Y1 - 2002/8

KW - Bone Neoplasms

KW - Carcinoma

KW - Combined Modality Therapy

KW - Disease Progression

KW - Female

KW - Follow-Up Studies

KW - Humans

KW - Middle Aged

KW - Ovarian Neoplasms

KW - Palliative Care

KW - Tomography, X-Ray Computed

U2 - 10.1016/S1470-2045(02)00821-5

DO - 10.1016/S1470-2045(02)00821-5

M3 - Article

C2 - 12147438

SN - 1470-2045

VL - 3

SP - 513

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 8

ER -